Chinese General Practice ›› 2023, Vol. 26 ›› Issue (27): 3403-3410.DOI: 10.12114/j.issn.1007-9572.2022.0887
• Article • Previous Articles Next Articles
Received:
2022-10-10
Revised:
2023-02-01
Published:
2023-09-20
Online:
2023-02-28
Contact:
TAN Rongshao
通讯作者:
谭荣韶
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0887
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 受教育程度(例数) | 婚姻状况(例数) | 身高( | 体质量〔M(P25,P75),kg〕 | BMI 〔M(P25,P75),kg/m2〕 | ||
---|---|---|---|---|---|---|---|---|---|
高中及以下 | 大专及以上 | 有配偶 | 无配偶(未婚、离异或丧偶) | ||||||
非肌少症患者组 | 39 | 42.0(34.0,51.0) | 16 | 23 | 29 | 10 | 168.4±5.8 | 65.0(60.0,74.5) | 24.1(21.5,26.0) |
肌少症患者组 | 12 | 41.5(31.0,44.5) | 5 | 7 | 8 | 4 | 168.8±5.0 | 56.0(50.0,58.0) | 19.2(17.4,21.5) |
检验统计量值 | -0.856a | 0.002b | 0.023b | 0.212 | -2.731a | -2.965a | |||
P值 | 0.392 | 0.969 | 0.769 | 0.833 | 0.006 | 0.003 | |||
组别 | ASM 〔M(P25,P75),kg〕 | SMI〔M(P25,P75),kg/m2〕 | 握力〔M(P25,P75),kg〕 | 捏力〔M(P25,P75),kg〕 | 小腿围( | MAC ( | TSF ( | AMC ( | |
非肌少症患者组 | 21.07(20.01,23.68) | 7.60(6.99,8.08) | 32.50(25.10,37.50) | 8.10(6.90,9.20) | 35.1±3.5 | 26.9±3.2 | 15.9±6.5 | 21.9±2.5 | |
肌少症患者组 | 17.68(16.82,18.63) | 6.51(6.09,6.65) | 22.90(21.35,25.55) | 6.10(5.80,7.48) | 31.5±2.1 | 24.2±2.1 | 10.4±8.0 | 21.0±2.8 | |
检验统计量值 | -3.620a | -3.953a | -2.942a | -2.299a | -3.369 | -2.770 | -2.436 | -1.156 | |
P值 | <0.001 | <0.001 | 0.003 | 0.021 | 0.001 | 0.008 | 0.019 | 0.254 | |
组别 | 腰围〔M(P25,P75),cm〕 | 臀围〔M(P25,P75),cm〕 | 腰臀比( | PhA 〔M(P25,P75)〕 | BCM 〔M(P25,P75),kg〕 | 细胞外液〔M(P25,P75),L〕 | 细胞内液〔M(P25,P75),L〕 | ||
非肌少症患者组 | 90.0(80.0,95.0) | 95.0(91.0,100.0) | 0.9±0.1 | 6.00°(5.30°,6.90°) | 32.0(28.0,38.1) | 16.80(15.30,17.50) | 22.40(19.60,27.40) | ||
肌少症患者组 | 80.0(78.5,86.0) | 90.0(88.0,93.0) | 0.9±0.1 | 5.10°(4.48°,5.80°) | 25.1(21.7,30.0) | 14.20(13.85,15.55) | 17.50(15.20,21.03) | ||
检验统计量值 | -1.828a | -2.159a | -0.622 | -2.666a | -3.142a | -2.821a | -3.132a | ||
P值 | 0.068 | 0.031 | 0.537 | 0.008 | 0.002 | 0.005 | 0.002 |
Table 1 Comparison of clinical data between male kidney transplant recipients with and without sarcopenia groups
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 受教育程度(例数) | 婚姻状况(例数) | 身高( | 体质量〔M(P25,P75),kg〕 | BMI 〔M(P25,P75),kg/m2〕 | ||
---|---|---|---|---|---|---|---|---|---|
高中及以下 | 大专及以上 | 有配偶 | 无配偶(未婚、离异或丧偶) | ||||||
非肌少症患者组 | 39 | 42.0(34.0,51.0) | 16 | 23 | 29 | 10 | 168.4±5.8 | 65.0(60.0,74.5) | 24.1(21.5,26.0) |
肌少症患者组 | 12 | 41.5(31.0,44.5) | 5 | 7 | 8 | 4 | 168.8±5.0 | 56.0(50.0,58.0) | 19.2(17.4,21.5) |
检验统计量值 | -0.856a | 0.002b | 0.023b | 0.212 | -2.731a | -2.965a | |||
P值 | 0.392 | 0.969 | 0.769 | 0.833 | 0.006 | 0.003 | |||
组别 | ASM 〔M(P25,P75),kg〕 | SMI〔M(P25,P75),kg/m2〕 | 握力〔M(P25,P75),kg〕 | 捏力〔M(P25,P75),kg〕 | 小腿围( | MAC ( | TSF ( | AMC ( | |
非肌少症患者组 | 21.07(20.01,23.68) | 7.60(6.99,8.08) | 32.50(25.10,37.50) | 8.10(6.90,9.20) | 35.1±3.5 | 26.9±3.2 | 15.9±6.5 | 21.9±2.5 | |
肌少症患者组 | 17.68(16.82,18.63) | 6.51(6.09,6.65) | 22.90(21.35,25.55) | 6.10(5.80,7.48) | 31.5±2.1 | 24.2±2.1 | 10.4±8.0 | 21.0±2.8 | |
检验统计量值 | -3.620a | -3.953a | -2.942a | -2.299a | -3.369 | -2.770 | -2.436 | -1.156 | |
P值 | <0.001 | <0.001 | 0.003 | 0.021 | 0.001 | 0.008 | 0.019 | 0.254 | |
组别 | 腰围〔M(P25,P75),cm〕 | 臀围〔M(P25,P75),cm〕 | 腰臀比( | PhA 〔M(P25,P75)〕 | BCM 〔M(P25,P75),kg〕 | 细胞外液〔M(P25,P75),L〕 | 细胞内液〔M(P25,P75),L〕 | ||
非肌少症患者组 | 90.0(80.0,95.0) | 95.0(91.0,100.0) | 0.9±0.1 | 6.00°(5.30°,6.90°) | 32.0(28.0,38.1) | 16.80(15.30,17.50) | 22.40(19.60,27.40) | ||
肌少症患者组 | 80.0(78.5,86.0) | 90.0(88.0,93.0) | 0.9±0.1 | 5.10°(4.48°,5.80°) | 25.1(21.7,30.0) | 14.20(13.85,15.55) | 17.50(15.20,21.03) | ||
检验统计量值 | -1.828a | -2.159a | -0.622 | -2.666a | -3.142a | -2.821a | -3.132a | ||
P值 | 0.068 | 0.031 | 0.537 | 0.008 | 0.002 | 0.005 | 0.002 |
组别 | 例数 | 年龄( | 受教育程度(例数) | 婚姻状况(例数) | 身高( | 体质量〔M(P25,P75),kg〕 | BMI 〔M(P25,P75),kg/m2〕 | ||
---|---|---|---|---|---|---|---|---|---|
高中及以下 | 大专及以上 | 有配偶 | 无配偶(未婚、离异或丧偶) | ||||||
非肌少症患者组 | 22 | 48.2±9.7 | 13 | 9 | 21 | 1 | 158.1±4.0 | 52.0(47.6,60.5) | 22.2(19.8,25.4) |
肌少症患者组 | 7 | 42.6±10.6 | 2 | 5 | 5 | 2 | 156.6±4.7 | 44.0(42.0,48.0) | 18.3(17.7,18.8) |
检验统计量值 | -1.317 | — | — | -0.809 | -2.363a | -2.854a | |||
P值 | 0.199 | 0.215 | 0.136 | 0.426 | 0.017 | 0.003 | |||
组别 | ASM 〔M(P25,P75),kg〕 | SMI〔M(P25,P75),kg/m2〕 | 握力( | 捏力( | 小腿围〔M(P25,P75),cm〕 | MAC ( | TSF ( | AMC ( | |
非肌少症患者组 | 15.36(14.16,18.54) | 6.13(5.72,7.46) | 18.31±7.60 | 5.31±1.79 | 33.0(31.4,34.6) | 25.6±3.1 | 19.3±9.1 | 19.4±3.0 | |
肌少症患者组 | 11.70(11.08,14.46) | 5.20(4.63,5.55) | 12.61±3.29 | 4.29±1.00 | 30.0(28.5,32.0) | 22.9±2.9 | 17.7±5.0 | 17.3±2.6 | |
检验统计量值 | -2.548a | -3.160a | -1.908 | -1.431 | -2.739a | -2.011 | -0.441 | -1.628 | |
P值 | 0.009 | 0.001 | 0.067 | 0.164 | 0.004 | 0.054 | 0.663 | 0.115 | |
组别 | 腰围〔M(P25,P75),cm〕 | 臀围〔M(P25,P75),cm〕 | 腰臀比〔M(P25,P75)〕 | PhA 〔M(P25,P75)〕 | BCM 〔M(P25,P75),kg〕 | 细胞外液〔M(P25,P75),L〕 | 细胞内液〔M(P25,P75),L〕 | ||
非肌少症患者组 | 76.0(73.0,82.5) | 90.0(86.5,95.8) | 0.8(0.8,0.9) | 5.50°(4.95°,6.28°) | 24.0(21.5,31.6) | 13.05(12.35,14.03) | 16.75(15.00,18.90) | ||
肌少症患者组 | 65.0(60.0,71.0) | 84.0(81.0,89.0) | 0.8(0.7,0.9) | 5.20°(3.70°,5.50°) | 18.1(17.4,23.9) | 10.70(9.70,12.70) | 12.70(12.20,16.70) | ||
检验统计量值 | -2.656a | -2.368a | -2.075a | -1.607a | -2.141a | -2.527a | -2.090a | ||
P值 | 0.006 | 0.017 | 0.036 | 0.110 | 0.032 | 0.009 | 0.037 |
Table 2 Comparison of clinical data between female kidney transplant recipients with and without sarcopenia
组别 | 例数 | 年龄( | 受教育程度(例数) | 婚姻状况(例数) | 身高( | 体质量〔M(P25,P75),kg〕 | BMI 〔M(P25,P75),kg/m2〕 | ||
---|---|---|---|---|---|---|---|---|---|
高中及以下 | 大专及以上 | 有配偶 | 无配偶(未婚、离异或丧偶) | ||||||
非肌少症患者组 | 22 | 48.2±9.7 | 13 | 9 | 21 | 1 | 158.1±4.0 | 52.0(47.6,60.5) | 22.2(19.8,25.4) |
肌少症患者组 | 7 | 42.6±10.6 | 2 | 5 | 5 | 2 | 156.6±4.7 | 44.0(42.0,48.0) | 18.3(17.7,18.8) |
检验统计量值 | -1.317 | — | — | -0.809 | -2.363a | -2.854a | |||
P值 | 0.199 | 0.215 | 0.136 | 0.426 | 0.017 | 0.003 | |||
组别 | ASM 〔M(P25,P75),kg〕 | SMI〔M(P25,P75),kg/m2〕 | 握力( | 捏力( | 小腿围〔M(P25,P75),cm〕 | MAC ( | TSF ( | AMC ( | |
非肌少症患者组 | 15.36(14.16,18.54) | 6.13(5.72,7.46) | 18.31±7.60 | 5.31±1.79 | 33.0(31.4,34.6) | 25.6±3.1 | 19.3±9.1 | 19.4±3.0 | |
肌少症患者组 | 11.70(11.08,14.46) | 5.20(4.63,5.55) | 12.61±3.29 | 4.29±1.00 | 30.0(28.5,32.0) | 22.9±2.9 | 17.7±5.0 | 17.3±2.6 | |
检验统计量值 | -2.548a | -3.160a | -1.908 | -1.431 | -2.739a | -2.011 | -0.441 | -1.628 | |
P值 | 0.009 | 0.001 | 0.067 | 0.164 | 0.004 | 0.054 | 0.663 | 0.115 | |
组别 | 腰围〔M(P25,P75),cm〕 | 臀围〔M(P25,P75),cm〕 | 腰臀比〔M(P25,P75)〕 | PhA 〔M(P25,P75)〕 | BCM 〔M(P25,P75),kg〕 | 细胞外液〔M(P25,P75),L〕 | 细胞内液〔M(P25,P75),L〕 | ||
非肌少症患者组 | 76.0(73.0,82.5) | 90.0(86.5,95.8) | 0.8(0.8,0.9) | 5.50°(4.95°,6.28°) | 24.0(21.5,31.6) | 13.05(12.35,14.03) | 16.75(15.00,18.90) | ||
肌少症患者组 | 65.0(60.0,71.0) | 84.0(81.0,89.0) | 0.8(0.7,0.9) | 5.20°(3.70°,5.50°) | 18.1(17.4,23.9) | 10.70(9.70,12.70) | 12.70(12.20,16.70) | ||
检验统计量值 | -2.656a | -2.368a | -2.075a | -1.607a | -2.141a | -2.527a | -2.090a | ||
P值 | 0.006 | 0.017 | 0.036 | 0.110 | 0.032 | 0.009 | 0.037 |
项目 | 例数 | ASM | SMI | 握力 | |
---|---|---|---|---|---|
男性 | 51 | rs(r)值 | 0.545 | 0.540 | 0.340 |
P值 | <0.001 | <0.001 | 0.015 | ||
女性 | 29 | rs(r)值 | 0.499 | 0.578 | 0.426a |
P值 | 0.006 | 0.001 | 0.021 |
Table 3 Correlation analysis between calf circumference and sarcopenia diagnostic indices in male and female kidney transplantation recipients
项目 | 例数 | ASM | SMI | 握力 | |
---|---|---|---|---|---|
男性 | 51 | rs(r)值 | 0.545 | 0.540 | 0.340 |
P值 | <0.001 | <0.001 | 0.015 | ||
女性 | 29 | rs(r)值 | 0.499 | 0.578 | 0.426a |
P值 | 0.006 | 0.001 | 0.021 |
变量 | 单因素Logistic | 多因素Logistic | ||||
---|---|---|---|---|---|---|
OR值 | 95%CI | P值 | OR值 | 95%CI | P值 | |
小腿围 | 0.648 | (0.507,0.828) | 0.001 | 0.699 | (0.501,0.975) | 0.035 |
体质量 | 0.926 | (0.875,0.980) | 0.008 | 1.019 | (0.929,1.117) | 0.691 |
臀围 | 0.878 | (0.797,0.968) | 0.009 | 0.972 | (0.805,1.172) | 0.764 |
BCM | 0.862 | (0.779,0.953) | 0.004 | 0.872 | (0.737,1.033) | 0.113 |
细胞外液 | 0.721 | (0.568,0.913) | 0.007 | 1.079 | (0.634,1.836) | 0.780 |
Table 4 Univariate and multivariate Logistic regression analyses of influencing factors of sarcopenia in kidney transplant recipients
变量 | 单因素Logistic | 多因素Logistic | ||||
---|---|---|---|---|---|---|
OR值 | 95%CI | P值 | OR值 | 95%CI | P值 | |
小腿围 | 0.648 | (0.507,0.828) | 0.001 | 0.699 | (0.501,0.975) | 0.035 |
体质量 | 0.926 | (0.875,0.980) | 0.008 | 1.019 | (0.929,1.117) | 0.691 |
臀围 | 0.878 | (0.797,0.968) | 0.009 | 0.972 | (0.805,1.172) | 0.764 |
BCM | 0.862 | (0.779,0.953) | 0.004 | 0.872 | (0.737,1.033) | 0.113 |
细胞外液 | 0.721 | (0.568,0.913) | 0.007 | 1.079 | (0.634,1.836) | 0.780 |
性别 | 最佳截断值(cm) | AUC(95%CI) | 灵敏度(%) | 特异度(%) | P值 |
---|---|---|---|---|---|
男性 | 33.3 | 0.799(0.663,0.898) | 83.3 | 74.4 | 0.002 |
女性 | 32.2 | 0.851(0.670,0.955) | 100.0 | 59.1 | 0.006 |
Table 5 Predictive values of calf circumference for sarcopenia in male and female kidney transplant recipients
性别 | 最佳截断值(cm) | AUC(95%CI) | 灵敏度(%) | 特异度(%) | P值 |
---|---|---|---|---|---|
男性 | 33.3 | 0.799(0.663,0.898) | 83.3 | 74.4 | 0.002 |
女性 | 32.2 | 0.851(0.670,0.955) | 100.0 | 59.1 | 0.006 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
袁丽,张鹏年,储霞飞,等. 术后时间不同的肾移植受者生活质量影响因素分析[J]. 安徽医药,2021,25(12):2398-2403. DOI:10.3969/j.issn.1009-6469.2021.12.016.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
郑伟,董云凤,黄灿,等. 基于多元线性回归模型的就业人员对财政收入的影响[J]. 安徽开放大学学报,2022(3):17-22,34. DOI:10.19371/j.cnki.issn1008-6021.2022.03.003.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[1] | ZHANG Aili, HOU Qiqi, HAN Quanle, ZHANG Boheng, ZHANG Jiawei, CAO Hongxia, ZHANG Chao, CHEN Shuohua, WU Shouling, LI Kangbo. Correlation between Atrial Fibrillation and the Risk of New-onset Chronic Kidney Disease in Northern Chinese Population [J]. Chinese General Practice, 2023, 26(36): 4521-4526. |
[2] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[3] | ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649. |
[4] | BAI Yitong, LIN Lianjie, PEI Dongmei. Correlation between the Severity of Metabolic-associated Fatty Liver Disease and Thyroid Nodules [J]. Chinese General Practice, 2023, 26(27): 3392-3396. |
[5] | SHANG Na, WANG Na, LIU Huizhen, LIU Lushan, WANG Yahui, GUO Shubin. Correlation between Nutrition-related Parameters and Frailty among Older Adults in the Emergency Department [J]. Chinese General Practice, 2023, 26(23): 2842-2847. |
[6] | LI Jingbo, PANG Gaofeng, REN Yanling, SHA Xixue, NI Huiping. Executive Function of GO/NOGO Paradigm Experiment in Children with Bronchial Asthma and Its Relationship with Pulmonary Function [J]. Chinese General Practice, 2023, 26(20): 2503-2507. |
[7] | LIU Yanhui, CHEN Shuchun. Interpretation and Clinical Significance of the Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement [J]. Chinese General Practice, 2023, 26(12): 1422-1428. |
[8] | QIAN Fangfang, CAI Zhensheng, GU Tian, LI Haoxiang, ZHAO Li, YANG Ling, DENG Xia, YUAN Guoyue. Relationship between Ectodysplasin A and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(08): 911-916. |
[9] | ZHAO Wei, YANG Shanshan, TANG Rongjie, YANG Fang, SUN Feng, LIAN Qiufang. Correlation between Serum Thyroid Hormone and Hyperuricemia in Euthyroid Hypertensive Patients [J]. Chinese General Practice, 2022, 25(35): 4394-4398. |
[10] | YANG Chen, HE Huajuan, LI Jianpu, CHEN Jun. Prevalence and Influencing Factors of Sarcopenia in Essential Hypertension [J]. Chinese General Practice, 2022, 25(35): 4381-4388. |
[11] | CHEN Ran, YANG Haoran, SHI Huilian, LIU Qiong, TANG Ting. Hotspots and Trends in Research on Nutrition in Cirrhosis from 1991 to 2021: a Visualized Review [J]. Chinese General Practice, 2022, 25(32): 4091-4098. |
[12] | Fangfang ZHANG, Yajing HU, Huayong HUANG, Jinhui NI, Ze YOU, Qiaoling CHANG, Li LIAO. Association of CT-assessed Sarcopenia with Postoperative Surgical Site Infections in Patients with Colorectal Cancer [J]. Chinese General Practice, 2022, 25(29): 3658-3663. |
[13] | WAN Jiamin,ZHAO Kexiang,SUN Yue,DENG Zidan,LUO Cheng,XIAO Qian. Advances in the Relationship between Osteosarcopenic Obesity Syndrome and Type 2 Diabetes [J]. Chinese General Practice, 2021, 24(9): 1152-1157. |
[14] | WANG Xiaoyan,WEI Feng,WANG Wei,ZHANG Yue,ZHOU Kun,ZHANG Yuan. Correlation of Serum Asprosin and Spexin Levels with Visceral Obesity in Type 2 Diabetics [J]. Chinese General Practice, 2021, 24(36): 4623-4627. |
[15] | LI Zhouhua,JI Shuang,HU Xianwei,YOU Qinghai,FEI Guanghe. Analysis of Risk Factors of Lung Cancer Patients Combined with Sarcopenia and Their Correlation with Clinical Prognosis [J]. Chinese General Practice, 2021, 24(26): 3310-3315. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||